A Study of UK-369,003 on the Safety and Efficacy in Patients With COPD

• Status: Completed
• Trial end date: 2005-12-01
• Target enrollment: 0
• Participant gender: All

Summary

A randomised, controlled study investigating the effect of UK-369,003 on exercise tolerance in patients with COPD

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer

Criteria

Inclusion Criteria:

• GOLD criteria 2 to 4

• 10 pack year history of smoking

Exclusion Criteria:

• Women of child bearing potential